COMMUNIQUÉS West-GlobeNewswire

New York Plastic Surgical Group Welcomes Two New Surgeons to Its Team
01/09/2026
Garden City, NY, Sept. 01, 2026 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group (NYPS Group), one of the nation's most respected plastic surgery practices, proudly welcomes two new surgeons, Steven Cai, MD , and Ian [...]
Inner Voyage Recovery Center earns The Joint Commission's Gold Seal of Approval following unannounced survey
01/09/2026
Woodstock outpatient program maintains national accreditation for behavioral health care after three-year review cycle Woodstock, GA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Inner Voyage Recovery Center, an outpatient [...]
BiomX Inc. to Become Tessera Defense and Homeland Security Inc.
01/09/2026
Name change effective September 11, 2026; common stock to trade on the NYSE American under the new symbol “HLSQ” NETANYA, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today [...]
Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer
01/09/2026
BEDMINSTER, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to JBS-003 (18F-fluoromisonidazole, [...]
Solera Health Adds Noom to Its Weight Management Network, Expanding Digital-First Options for Members
01/09/2026
Partnership brings CDC Full Plus-recognized diabetes prevention program and a no-cost GLP-1 Companion offering to Solera's curated network, in addition to its Noom Weight offering PHOENIX, Sept. 01, 2026 (GLOBE NEWSWIRE [...]
Editas Medicine to Participate in Upcoming Investor Conferences
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that [...]
Olympia Pharmaceuticals Adds Gonadorelin to Its Growing Men’s Hormone Portfolio
01/09/2026
A synthetic copy of the hormone signal that prompts the body to make testosterone, the new 1 mg/mL formulation is now available to providers in 49 states for office use ORLANDO, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- [...]
Patients Suffering from Primary Biliary Cholangitis (PBC) Push Back on Stigma
01/09/2026
National Voice of PBC Survey Unveils the Significant Physical, Emotional and Social Impact of PBC ROCHESTER, N.Y., Sept. 01, 2026 (GLOBE NEWSWIRE) -- This September, in recognition of PBC Awareness Month, The PBCers [...]
Aeroflow Health Partners with Fallon Health to Expand DME Access to Commercial and Medicare Members in Massachusetts
01/09/2026
Commercial and Medicare members under Fallon Health gain easy access to critical care supplies such as breast pumps and CPAPs. ASHEVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a technology-enabled [...]
Easy Environmental Solutions Reports Fiscal 2026 Results and Continued Revenue Growth
01/09/2026
Annual filing reflects substantial year-over-year revenue growth, improved operating performance and positive operating cash flow MANKATO, Minn., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. ( [...]
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
01/09/2026
Multi-site clinical study delivers strong performance data for Intelligent Fingerprinting Drug Screening System NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the " [...]
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
01/09/2026
PARSIPPANY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]
SCYNEXIS to Participate in Upcoming Investor Conferences
01/09/2026
JERSEY CITY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX), a clinical-stage biotechnology company focused on developing innovative therapies for severe and difficult-to-treat diseases with [...]
CytoDyn Closes $16.5 Million Financing to Fund Continued Development of Leronlimab
01/09/2026
VANCOUVER, Washington, Sept. 01, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
01/09/2026
EMERYVILLE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative [...]
CytomX Therapeutics to Present at Upcoming September Investor Conferences
01/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will [...]
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
01/09/2026
GAITHERSBURG, Md., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification valued at approximately $24 million from the Biomedical Advanced Research and [...]
Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial
01/09/2026
Milestone marks transition to active site-level execution with patient screening and enrollment expected to begin shortly SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical [...]
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
01/09/2026
ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have [...]

Pages